Pharma as a Hurdle for Federal Legalization

TerrAscend's Executive Chairman Jason Wild returns. Focused on not spreading itself too thin ("we'd rather be more focused, spend more money, get more scale, like we did in Jersey") and why not all EBITDA numbers are created equally (8:50). Should cannabis companies pay their taxes? (11:40) Pushing for real legislative change with famed lawyer David Boies (13:30).

Show Notes:
TerrAscend GAAP EPS of -$0.04
Better Margins In Cannabis

Episode Transcripts

For full access to analyst ratings, stock quant scores as well as dividend grades, sign up at https://seekingalpha.com/subscriptions.